Catalent Pharma Solutions has completed the second phase of an expansion programme at its facility in Kansas City, Missouri.

The $5.5m expansion programme will allow the company to enhance the controlled-substance and controlled-temperature storage capabilities for its clinical supply business.

With the completion of the programme, the company has concluded a two-year project that has also expanded the facility’s highly-potent, cytotoxic and cold storage clinical drug packaging capabilities.

"These latest expansions are critical enablers to our customers’ continued growth that reinforce our comprehensive global network, and enhance Catalent’s role as a market leader in the clinical supply industry."

Catalent provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products.

The latest expansion, which includes a new Drug Enforcement Administration (DEA) Schedule I and II controlled substance vault, adds 3,600ft² of storage.

In addition, the facility will have additional controlled temperature storage capacity with 450 new pallet locations and 500 new high-density storage locations.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In order to ensure the security and integrity of samples in storage, the company has also added a new sampling room and an emergency generator.

Catalent Pharma Solutions Clinical Supply Services general manager Kevin Economos said: “Catalent customers have benefitted from our integrated analytical, oral solid manufacturing, and clinical supply services which our Kansas City campus has offered continuously for over 18 years.

“These latest expansions are critical enablers to our customers’ continued growth that reinforce our comprehensive global network, and enhance Catalent’s role as a market leader in the clinical supply industry.”

The services provided by the company at the 450,000ft² Kansas City facility include development and analytical support, as well as packaging and distribution.

Recently, Catalent announced new capabilities and capacity at two of its other clinical supply facilities in Philadelphia and Singapore.